1
Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)
Condition(s): Brain Cancer; Glioblastoma Last Updated: April 22, 2013Recruiting
56 Clinical Trials for: “Lomustine”, Page 1 of 3
Hide Studies Not Seeking New Volunteers
2
Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients
Condition(s): Brain Neoplasms; Melanoma Last Updated: October 5, 2012Completed
3
Procarbazine and Lomustine in Recurrent Glioblastoma
Condition(s): Recurrent Glioblastoma Multiforme Last Updated: November 30, 2012Recruiting
4
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
Condition(s): Recurrent Glioblastoma; Brain Tumor Last Updated: November 24, 2009Completed
5
Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients
Condition(s): Glioblastoma Last Updated: July 31, 2012Recruiting
6
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
Condition(s): Recurrent Glioblastoma Last Updated: March 1, 2013Active, not recruiting
7
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
Condition(s): Anaplastic Glioma of Brain; Glioblastoma Multiforme; Brain Cancer Last Updated: December 6, 2011Completed
8
Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)
Condition(s): Glioblastoma Last Updated: August 27, 2012Terminated
9
Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas
Condition(s): Brain and Central Nervous System Tumors Last Updated: March 6, 2013Completed
10
Adding Lomustine to Chemotherapy in Older Patients With Acute Myelogenous Leukemia (AML), and Allogeneic Transplantation for Patients From 60 to 65 Years Old
Condition(s): Acute Myeloid Leukemia Last Updated: February 27, 2013Active, not recruiting
11
Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Condition(s): Glioblastoma Last Updated: March 27, 2008Completed
12
A Clinical Trial to Assess the Safety & Efficacy of the Treatment of Patients With Metastasis From Malignant Melanoma - Treatment Consists of the Substances Lomustine (Capsules) & Cytarabine (Injected Into an Area Near the Spinal Cord), Accompanied by Radiotherapy of the Brain
Condition(s): Leptomeningeal Metastasis From Malignant Melanoma Last Updated: February 26, 2013Active, not recruiting
13
A Study in Recurrent Glioblastoma (GB)
Condition(s): Glioblastoma Last Updated: May 14, 2013Recruiting
14
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
Condition(s): Acute Myeloid Leukemia Last Updated: May 29, 2007Completed
15
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin Lymphoma
Condition(s): AIDS-related Diffuse Large Cell Lymphoma; AIDS-related Diffuse Mixed Cell Lymphoma; AIDS-related Diffuse Small Cleaved Cell Lymphoma; AIDS-related Immunoblastic Large Cell Lymphoma; AIDS-related Lymphoblastic Lymphoma; AIDS-related Peripheral/Systemic Lymphoma; AIDS-related Small Noncleaved Cell Lymphoma; Stage III AIDS-related Lymphoma; Stage IV AIDS-related Lymphoma Last Updated: January 23, 2013Not yet recruiting
16
Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition(s): Lung Cancer Last Updated: May 3, 2013Completed
17
Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Condition(s): Anaplastic Astrocytoma; Glioblastoma Last Updated: January 30, 2013Terminated
18
A Dose-Escalation Study in Participants With Recurrent Malignant Glioma
Condition(s): Glioma Last Updated: September 6, 2012Completed
19
Enzastaurin Versus Lomustine in Glioblastoma
Condition(s): Glioblastoma Last Updated: December 20, 2012Active, not recruiting
20
Bevacizumab and Lomustine in Treating Patients With Glioblastoma Multiforme in First Recurrence
Condition(s): Brain and Central Nervous System Tumors; Cognitive/Functional Effects Last Updated: September 15, 2011Not yet recruiting
